Rocket Pharmaceuticals, Inc. (RCKTW) — 10-Q Filings
All 10-Q filings from Rocket Pharmaceuticals, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Rocket Pharma Narrows Losses Amid R&D Cuts, Cash Burn Continues
— Nov 6, 2025 Risk: high
Rocket Pharmaceuticals, Inc. reported a net loss of $50,332 thousand for the three months ended September 30, 2025, an improvement from a net loss of $66,719 th - 10-Q Filing — Aug 7, 2025
- 10-Q Filing — May 8, 2025
-
Rocket Pharmaceuticals Files Q3 2024 10-Q
— Nov 7, 2024 Risk: medium
Rocket Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The company's financial statements and disclosures are presented, includin -
Rocket Pharmaceuticals Q2 2024 Update
— Aug 6, 2024 Risk: medium
Rocket Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported research and development expenses for the three months end -
Rocket Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: low
ROCKET PHARMACEUTICALS, INC. (RCKTW) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Rocket Pharmaceuticals, Inc. filed a 10-Q report for the perio
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX